Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia · Delayed Price · Currency is MYR 1.330
+0.040 (3.10%)
At close: Jun 9, 2026
Pharmaniaga Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 50.4 | 48.51 | 131.82 | -80.16 | -629.92 | 172.15 |
Depreciation & Amortization | 34.96 | 35.22 | 38.35 | 38.77 | 34.02 | 31.7 |
Other Amortization | 5.57 | 4.08 | 3.03 | 2.93 | 2.41 | 1.68 |
Other Operating Activities | -151.61 | -105.5 | -130.53 | 85.41 | 451.15 | -269.58 |
Operating Cash Flow | -60.67 | -17.69 | 42.67 | 46.95 | -142.34 | -64.06 |
Operating Cash Flow Growth | - | - | -9.12% | - | - | - |
Capital Expenditures | -29.94 | -29.78 | -31.16 | -50.67 | -59.26 | -30.39 |
Sale of Property, Plant & Equipment | 0.24 | 0.29 | 0.08 | 1.32 | 0.06 | 0.21 |
Sale (Purchase) of Intangibles | -8.4 | -8.89 | -8.41 | -10.34 | -18.38 | -14.97 |
Other Investing Activities | 6.13 | -141.86 | -6.13 | -8.24 | 5.25 | -0.41 |
Investing Cash Flow | -31.97 | -180.24 | -45.62 | -67.93 | -72.34 | -45.56 |
Short-Term Debt Issued | - | - | - | 50 | - | - |
Long-Term Debt Issued | - | 1,956 | 2,150 | 3,248 | 2,291 | 2,329 |
Total Debt Issued | 1,956 | 1,956 | 2,150 | 3,298 | 2,291 | 2,329 |
Long-Term Debt Repaid | - | -2,305 | -2,139 | -3,240 | -1,988 | -2,149 |
Total Debt Repaid | -2,290 | -2,305 | -2,139 | -3,240 | -1,988 | -2,149 |
Net Debt Issued (Repaid) | -334.17 | -349.55 | 10.67 | 57.48 | 303.42 | 179.73 |
Issuance of Common Stock | 569.57 | 569.57 | - | 45.86 | - | - |
Common Dividends Paid | - | - | - | -7.86 | -82.53 | -58.95 |
Other Financing Activities | -55.4 | -55.4 | 11.43 | -0.21 | -0.1 | -0.04 |
Financing Cash Flow | 180 | 164.62 | 22.1 | 95.27 | 220.79 | 120.74 |
Foreign Exchange Rate Adjustments | -2.14 | -2.18 | -0.52 | 0.31 | -0.39 | 0.13 |
Net Cash Flow | 85.21 | -35.49 | 18.64 | 74.59 | 5.74 | 11.25 |
Free Cash Flow | -90.61 | -47.47 | 11.51 | -3.72 | -201.6 | -94.44 |
Free Cash Flow Margin | -2.24% | -1.21% | 0.31% | -0.11% | -5.79% | -1.96% |
Free Cash Flow Per Share | -0.02 | -0.01 | 0.01 | -0.00 | -0.15 | -0.07 |
Cash Interest Paid | 55.18 | 62.53 | 68.11 | 60.81 | 41.29 | 32.63 |
Cash Income Tax Paid | 28.55 | 29.43 | 33.89 | 20.56 | 39.52 | 39.7 |
Levered Free Cash Flow | -118.7 | -51.97 | -15.34 | 31.75 | 479.12 | -143.76 |
Unlevered Free Cash Flow | -84.87 | -13.63 | 29.64 | 70.4 | 504.15 | -122.93 |